XFOR icon

X4 Pharmaceuticals
XFOR

Overview Fund Activity

91 hedge funds and large institutions have $123M invested in X4 Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
-4
Holders Change %
-4.21%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
27
Reduced
26
Closed
15
Calls
$323K
Puts
$494K
Net Calls
-$171K
Net Calls Change
-$9.23M

Top Buyers

1
PCH
1
Polar Capital Holdings
United Kingdom
$8.18M
2
TLP
2
Tri Locum Partners
New York
$6.81M
3
UOC
3
UBS O'Connor
Illinois
$1.7M
4
SCM
4
Sio Capital Management
New York
$2.83M
5
SCM
5
Stonepine Capital Management
Oregon
$5.75M

Top Sellers

1
CH
1
CVI Holdings
Delaware
$0
2
PHP
2
Parkman Healthcare Partners
Connecticut
$872K
3
Millennium Management
3
Millennium Management
New York
$3.94M
4
Citadel Advisors
4
Citadel Advisors
Florida
$1.96M
5
EI
5
EAM Investors
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Belvedere Trading
101
Belvedere Trading
Illinois
– -$55.8K -959 Closed
State of Wisconsin Investment Board
102
State of Wisconsin Investment Board
Wisconsin
– -$46.2K -793 Closed
VF
103
Virtu Financial
New York
– -$29K -503 Closed
MWM
104
Mission Wealth Management
California
– -$29.1K -500 Closed
V
105
Veritable
Delaware
– -$24.5K -421 Closed
IGWM
106
ICA Group Wealth Management
Colorado
– -$2.62K -45 Closed
1 2 3 4
5